Research question
- An Ov16/OVOC3261 biplex IgG4 test, whereby we are confident that we can provide > 60% sensitivity and 99.8% specificity, as required by the TPP for Onchocerciasis Elimination Mapping.
- Demonstration that the Ov16/OVOC3261 biplex IgG4 test behaves at least as good with blood as with plasma/serum samples (notably a perceived weakness of the SD Ov16 RDT)
Study sites
Regional Study Site, United States
In progress
Implementation partner(s)
This study is In progress
Contact
Ashley Souza
Lead institution(s)
Other collaborator(s)
Funding partner(s)
Reference information
This project was funded by the NTD Support Centre
NTD-SC #
226
Tags
Disease(s)
Onchocerciasis
Research topic(s)
Diagnostics
Study design(s)
Case-control
Comparative-effectiveness study
Indicator(s)
Other indicator category